Hypofractionation Radiotherapy vs. Conventional Fractionation for Breast Cancer: A Comparative Review of Toxicity
- PMID: 30648051
- PMCID: PMC6318139
- DOI: 10.7759/cureus.3516
Hypofractionation Radiotherapy vs. Conventional Fractionation for Breast Cancer: A Comparative Review of Toxicity
Abstract
The use of postoperative radiation therapy after breast-conserving surgery was longstanding standard practice. The treatment protocol used a standard fractionation of 50 Gy in 25 fractions plus a boost. Recently, the hypofractionation approach has gained support based on Canadian and English studies that claimed equal tumor control and similar toxicity to the standard protocol. We conducted a review of the literature of hypofractionation studies and compared the reported toxicity with the general literature. We placed special emphasis on breast fibrosis after hypofractionation versus standard fractionation. We found a striking difference in the breast toxicity reported by the hypofractionation literature regarding breast fibrosis as compared to standard fractionation. Breast fibrosis should be explored further via additional studies and discussed with potential breast-conserving surgery patients.
Keywords: breast cancer; breast fibrosis; hypofractionated; radiation therapy; standard fractionation.
Conflict of interest statement
The authors have declared that no competing interests exist.
Similar articles
-
Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): acute toxicity results from a randomised non-inferiority phase 3 trial.Lancet Oncol. 2015 Mar;16(3):274-83. doi: 10.1016/S1470-2045(14)70482-6. Epub 2015 Feb 3. Lancet Oncol. 2015. PMID: 25656287 Clinical Trial.
-
Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): late toxicity results from a randomised, non-inferiority, phase 3 trial.Lancet Oncol. 2016 Apr;17(4):464-474. doi: 10.1016/S1470-2045(15)00567-7. Epub 2016 Mar 9. Lancet Oncol. 2016. PMID: 26968359 Clinical Trial.
-
Hypofractionated and hyper-hypofractionated radiation therapy in postoperative breast cancer treatment.Rev Assoc Med Bras (1992). 2020 Sep;66(9):1301-1306. doi: 10.1590/1806-9282.66.9.1301. Rev Assoc Med Bras (1992). 2020. PMID: 33027462 Review.
-
Analysis of Outcomes Using Hypofractionated Tumor Bed Boost Combined With Hypofractionated Whole Breast Irradiation for Early-stage Breast Cancer.Clin Breast Cancer. 2017 Dec;17(8):638-643. doi: 10.1016/j.clbc.2017.05.010. Epub 2017 May 25. Clin Breast Cancer. 2017. PMID: 28629952
-
Hypofractionated whole breast radiotherapy: current perspectives.Breast Cancer (Dove Med Press). 2015 Oct 27;7:363-70. doi: 10.2147/BCTT.S81710. eCollection 2015. Breast Cancer (Dove Med Press). 2015. PMID: 26604820 Free PMC article. Review.
Cited by
-
MicroRNA-21 is Required for Hematopoietic Cell Viability After Radiation Exposure.Int J Radiat Oncol Biol Phys. 2019 Aug 1;104(5):1165-1174. doi: 10.1016/j.ijrobp.2019.04.020. Epub 2019 Apr 27. Int J Radiat Oncol Biol Phys. 2019. PMID: 31039423 Free PMC article.
-
Autologous fat grafting in breast reconstruction: implications for follow-up and surveillance.Gland Surg. 2021 Jan;10(1):487-493. doi: 10.21037/gs.2020.04.04. Gland Surg. 2021. PMID: 33634006 Free PMC article. Review.
-
Effectiveness of hypofractionated and normofractionated radiotherapy in a triple-negative breast cancer model.Front Oncol. 2022 Oct 27;12:852694. doi: 10.3389/fonc.2022.852694. eCollection 2022. Front Oncol. 2022. PMID: 36387199 Free PMC article.
-
Autotaxin and Breast Cancer: Towards Overcoming Treatment Barriers and Sequelae.Cancers (Basel). 2020 Feb 6;12(2):374. doi: 10.3390/cancers12020374. Cancers (Basel). 2020. PMID: 32041123 Free PMC article. Review.
-
Ultrasound Findings After Breast Cancer Radiation Therapy: Cutaneous, Pleural, Pulmonary, and Cardiac Changes.Korean J Radiol. 2024 Nov;25(11):982-991. doi: 10.3348/kjr.2024.0672. Korean J Radiol. 2024. PMID: 39473089 Free PMC article. Review.
References
-
- Radiation therapy for the whole breast: executive summary of an American Society of Radiation Oncology (ASTRO) evidence-based guideline. Smith BD, Bellon JR, Blitzblau R, et al. Pract Radiat Oncol. 2018;8:145–152. - PubMed
-
- Long-term results of hypofractionated radiation therapy for breast cancer. Whelan TJ, Pignol JP, Levine MN, et al. N Engl J Med. 2010;362:513–520. - PubMed
-
- Randomized trial of breast irradiation schedules after lumpectomy for women with lymph node-negative breast cancer. Whelan T, MacKenzie R, Julian J, et al. J Natl Cancer Inst. 2002;94:1143–1150. - PubMed
Publication types
LinkOut - more resources
Full Text Sources